Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery

OBJECTIVE: Stereotactic radiosurgery (SRS) is routinely used to treat brain metastases from melanoma due to their radioresistant nature. The median survival for these patients is 4–6 months, according to earlier studies. The aim of this study was to evaluate prognostic factors that influence surviva...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurosurg
Main Authors: Bian, Shelly X., Routman, David, Liu, Jonathan, Yang, Dongyun, Groshen, Susan, Zada, Gabriel, Trakul, Nicholas, Wong, Michael K., Yu, Cheng, Chang, Eric L.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7469983/
https://ncbi.nlm.nih.gov/pubmed/27903181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2016.8.GKS161359
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares